Navigation Links
Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium
Date:9/9/2011

SAN FRANCISCO, Sept. 9, 2011 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that positive results from the company's Phase 2 clinical study of NKTR-102 in patients with metastatic breast cancer were presented at the ASCO 2011 Breast Cancer Symposium in San Francisco, California.  NKTR-102 is a novel topoisomerase I inhibitor designed using Nektar's proprietary polymer conjugate technology, and is being developed in multiple tumor settings.  

"NKTR-102 exhibits a very high response rate and excellent clinical benefit rate in patients with metastatic breast cancer, and importantly, this anti-tumor activity is maintained in each of the poor prognosis subsets within the study," said presenter and NKTR-102 study investigator, Dr. Agustin Garcia, Associate Professor of Clinical Medicine at USC Norris Comprehensive Center.  "The data from the Phase 2 study also shows highly promising PFS of 5.3 months and OS of 13.1 months in the every three week dose schedule, which was also very well-tolerated.   As a novel topoisomerase I inhibitor in breast cancer, NKTR-102 holds great therapeutic potential and allows us to address the challenge of resistance in this setting.  The investigators look forward to the initiation of the Phase 3 BEACON study of NKTR-102 in patients with metastatic breast cancer."  

More than one million women worldwide are diagnosed with breast cancer every year and the disease is the leading cause of cancer-related death among women.(1)  

Highlights from the Phase 2 Clinical Data PresentationThe randomized Simon two-stage study of single-agent NKTR-102 evaluated two 145 mg/m2 dose schedules of NKTR-102, every two weeks (q14d) and every three weeks (q21d), in 70 metastatic breast cancer patients.  NKTR-102 achieved a confirmed objective response rate by RECIST of 29 percent.  In addition
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)...  Hill-Rom Holdings, Inc. (NYSE: HRC ) ... been elected to its Board of Directors.  She most ... as well as President of Covidien,s Vascular Therapies Division ... 2010 to 2012. Ms. Enxing Seng joined ... Incorporated, where she was a founding member and executive ...
(Date:3/4/2015)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... II proof of concept clinical study investigating the ... in the treatment of chronic pruritus in patients ... clinically meaningful improvement from baseline by tradipitant (40.5mm ... 100mm unit Visual Analog Scale (VAS) for itch, ...
(Date:3/4/2015)... 2015  The strongest driver of demand in ... elderly population, according to Kalorama Information. The finding ... healthcare market research publisher, Global Orthopedic Device ... factors such as obesity is contributing to the ... product designs and the trend toward cost effective ...
Breaking Medicine Technology:Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7Kalorama: Growing Elderly Population Drives Orthopedic Device Market 2Kalorama: Growing Elderly Population Drives Orthopedic Device Market 3
... PLANO, Texas, Dec. 1, 2011 /PRNewswire-iReach/ -- ... medical real estate development and medical investment solutions is ... Pedro Vergne-Marini, MD to its publication, "350 People in ... leaders who shape the ambulatory surgery center industry through ...
... Dec. 1, 2011 Hologic, Inc. (NASDAQ: HOLX ... Chief Financial Officer, will be presenting at the Nasdaq OMX ... at 11:15am (GMT). Interested parties are invited to ... on the investor section of Hologic,s website at www.hologic.com/investors-overview ...
Cached Medicine Technology:Physicians' Capital Investments Announces Pedro Vergne-Marini, MD Named to Becker's ASC Review "350 People in the ASC Industry to Know" 2Physicians' Capital Investments Announces Pedro Vergne-Marini, MD Named to Becker's ASC Review "350 People in the ASC Industry to Know" 3Physicians' Capital Investments Announces Pedro Vergne-Marini, MD Named to Becker's ASC Review "350 People in the ASC Industry to Know" 4
(Date:3/4/2015)... March 05, 2015 The emergence ... landscape over the past decade. The pharmaceutical world ... drug delivery in the form of liposomes and ... drugs with more safety and efficiency. In ... perhaps rely greatly upon the enhanced permeability and ...
(Date:3/4/2015)... Nashville, Tenn. (PRWEB) March 04, 2015 Imagine ... to receive the Care2 Innovator Award , an honor ... was presented today at the Nonprofit Technology Conference ... pastor of Tarrytown United Methodist Church in Austin, was on ... Executive Committee for Imagine No Malaria. , Imagine No Malaria ...
(Date:3/4/2015)... In the Ultimate Fighting Championship, each event is ... event. For UFC 189 , just one official fight ... UFC Featherweight Championship. Brazilian champion Jose “Junior” Aldo will defend ... Conor “Notorious” McGregor. UFC 189 will take place on July ... NV. , When it comes to the featherweight division in ...
(Date:3/4/2015)... 2015 The Asia-Pacific phthalic anhydride ... $5,632.8 million by 2019, at a CAGR of ... 2019. , Browse through the TOC of Asia-Pacific ... trends and segments, with the help of various ... Anhydride (PA) is a derivative of phthalic acid, ...
(Date:3/4/2015)... Ultraman Florida is a grueling extreme athletic ... bike, and 52.4 mile run. Christian Isakson finished in ... "This race was awesome and tough," Isakson said. "I ... for supporting me through every part of this brutal ... of 40 select participants invited from across the United ...
Breaking Medicine News(10 mins):Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 2Health News:Cancer Nanomedicine Marketplace Discussed by Kuick Research in Topical Study Recently Published at MarketPublishers.com 3Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2
... HILLSBOROUGH, N.C., Sept. 21 Whether it is bragged ... always memorable. A recent study by Adam & Eve shows that ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090921/LA79100 ) , , ... Adam & Eve, the most trusted name in adult entertainment, recently ...
... , , NEW YORK, Sept. 21 ... dramatic increase of Substance Abuse (SA) and co-occurring mental health disorders among ... core mission is to raise funds for veterans who need treatment for ... heal the war within. , , "For veterans suffering ...
... Sept. 21 Back to School season is here and so are ... solutions are all true, and the answer lies in natural solutions, according ... by prescription, are designed to kill lice but do not remove or ... and there,s a brand new case of head lice. With most so ...
... , SOUTHBURY, Conn., Sept. 21 Karen Powell, founder ... market leader and second largest interior design franchise, met with members ... important to the franchise industry during the International Franchise Association (IFA) ... , , Powell joined 450 franchise leaders ...
... , SACRAMENTO, Calif., Sept. 21 Former California ... of a Purple Ribbon Panel and Task Force starting work today ... to double among Californians by the year 2030. The state has ... , Brown will be joined by Lloyd Dean, ...
... , ... EMS professionals to earn continuing education credits online , ... Lincoln, Neb. (Vocus) September 21, 2009 -- ... courses offered by Health Education Solutions (HES) recently received accreditation from the Continuing Education ...
Cached Medicine News:Health News:Adam & Eve's 'Great American Sex Survey' Asks 'How Was YOUR First Time?' 2Health News:Veterans Healing Initiative Formed to Help Meet Burgeoning Addiction and Mental Health Issues of Returning U.S. Veterans 2Health News:Head Lice Meet Their Natural Match - Leading Experts Say Safe Solution Proves Best for Lice and Nit Removal 2Health News:Southbury Franchise Industry Leader Urges Congress to Consider Small Businesses in Healthcare Debate 2Health News:Elaine Alquist, Willie Brown and Kim Belshe Convene Purple Ribbon Panel, Task Force on Alzheimer's 2Health News:Health Education Solutions' Advanced Cardiac Life Support and Pediatric Advanced Life Support Courses Receive Accreditation 2Health News:Health Education Solutions' Advanced Cardiac Life Support and Pediatric Advanced Life Support Courses Receive Accreditation 3
Shandon Slide Mailers and Envelopes...
Shandon Stackable Slide Storage Cabinet...
Shandon Slide File Storage System...
Shandon Plastic Slide Boxes...
Medicine Products: